TSS
HQL

Two Sigma Securities’s abrdn Life Sciences Investors HQL Stock Holding History

Two Sigma Securities’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-16,108
Closed -$243K – 2093
2018
Q4 		$243K Buy
+16,108
New +$284K ﹤0.01% 1547

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Two Sigma Securities's HQL Position: Q1 2019 in Review

Two Sigma Securities sold out of abrdn Life Sciences Investors (HQL) in Q1 2019, closing a stake of 16,108 shares — an estimated $243K sold.

Two Sigma Securities first reported a position in HQL in Q4 2018 and held it in 1 quarter. The position peaked at $243K in Q4 2018. 56 funds tracked by Wall St. Rank hold HQL as of Q1 2019.

  • Two Sigma Securities reported no remaining abrdn Life Sciences Investors position as of Q1 2019 after selling out during the quarter.
  • Two Sigma Securities sold 16,108 abrdn Life Sciences Investors shares in Q1 2019, an estimated $243K.
  • Two Sigma Securities first reported a position in abrdn Life Sciences Investors in Q4 2018 and held it in 1 quarter.
  • Two Sigma Securities's abrdn Life Sciences Investors position peaked at $243K in Q4 2018.
  • 56 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2019.

Based on Two Sigma Securities's 13F filing for Q1 2019, filed 15 May 2019.